News
Researchers discover a new genetic regulation pathway associated with obesity
The results of the study, published in the journal Advanced Science, show that reducing the expression of a group of microRNAs in fat tissue causes an increase in the number of fat-storing cells and their hypertrophic growth.
CAC, IDIBELL, and Hospital de Bellvitge offer scholar course to prevent addictions to video games and gambling
It reflects on the time spent playing, the stereotypes and values that video games can transmit
The DACMA Association donates 8,000 euros for breast cancer research
The Association of Women with Breast Cancer (DACMA) has donated a check for 8,000 euros to IDIBELl and ICO dedicated to breast cancer research. This donation counted on the participation of Belén García, the mayor of Sant Joan Despí, where DACMA has its headquarters, who wanted to accompany the entity members in this event.
From lab to market: the fourth edition of the Accelerator Meeting Point promotes Bellvitge’s biomedical innovation
The most innovative projects in the healthcare and biomedical sector were presented on December the 16th at the fourth edition of the Accelerator Meeting Point (AMP), organized by the Business Development and Innovation Area of the Biomedical Research Institute of Bellvitge (IDIBELL). The fourth edition of the AMP has counted on the participation of AIISEM, […]
New diagnostic technique for HPV detection in oropharyngeal cancers
The new trial allows human papilloma virus (HPV) detection and genotyping with the same sensitivity as other commonly used PCRs but following a much simpler procedure.
Scientists describe how vaccination has affected bacterial variants that cause pneumonia
Un estudio del IDIBELL y el Hospital Universitario de Bellvitge ha descrito como las vacunas han cambiado la distribución de los distintos serotipos de neumococo.
Scientists discover an essential mechanism for maintaining bone density
A research group of IDIBELL and UB has revealed the importance of the function of NRF2, a protein that regulates the expression of some genes in response to oxidative radicals, in the maintenance of bone tissue.
IDIBELL and Shenzhen Bay Laboratory launch an international exchange program for predoctoral researchers
The new program, following IDIBELL’s strategic plan, aims to promote interaction between both institutions and reinforce scientific collaboration.
New clinical trial for adrenoleukodystrophy, a rare disease of brain metabolism
The IDIBELL Neurometabolic Diseases team, which is also part of CIBERER, plans to start the study in early 2022 with the anti-inflammatory dimethyl fumarate in patients with this condition.